| Dr Jason Thomas Palik, OD | |
|
23 Crossroads Dr, Suite #310, Owings Mills, MD 21117-5420 | |
| (410) 581-1500 | |
| (410) 581-0577 |
| Full Name | Dr Jason Thomas Palik |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 19 Years |
| Location | 23 Crossroads Dr, Owings Mills, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407882129 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TA1955 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chesapeake Eye Care And Laser Center Llc | 2769460971 | 74 |
| Brull And Honig Md Pa | 6800807009 | 3 |
News Archive
As the COVID-19 pandemic continues to cause an immense impact across many parts of the world, the role played by immune responses is becoming more evident every day. A recent funded paper published on the preprint server medRxiv* in September 2020 reports the initiation of a Phase I trial of a drug that increases antibody and cell-mediated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Iowa State researchers have found for the first time that less muscle and more body fat may affect our thinking as we age, and changes in parts of the immune system could be responsible.
Genmab A/S announced today an agreement to create and develop human antibody therapeutics for disorders of the central nervous system (CNS) with H. Lundbeck A/S. Genmab will create novel human antibodies to three targets identified by Lundbeck. Lundbeck will have access to Genmab's antibody creation and development capabilities, including its state of the art, fully automated pre-clinical antibody screening and characterization capabilities and its proprietary stabilized IgG4 and UniBody therapeutic antibody platforms.
Neurosurgery researchers at UC Davis Health System have used a new, leading-edge stem cell therapy to promote the growth of bone tissue following the removal of cervical discs - the cushions between the bones in the neck - to relieve chronic, debilitating pain.
› Verified 1 days ago
| Provider Name | Chesapeake Eye Care & Laser Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1548296262 PECOS PAC ID: 2769460971 Enrollment ID: O20040713000454 |
News Archive
As the COVID-19 pandemic continues to cause an immense impact across many parts of the world, the role played by immune responses is becoming more evident every day. A recent funded paper published on the preprint server medRxiv* in September 2020 reports the initiation of a Phase I trial of a drug that increases antibody and cell-mediated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Iowa State researchers have found for the first time that less muscle and more body fat may affect our thinking as we age, and changes in parts of the immune system could be responsible.
Genmab A/S announced today an agreement to create and develop human antibody therapeutics for disorders of the central nervous system (CNS) with H. Lundbeck A/S. Genmab will create novel human antibodies to three targets identified by Lundbeck. Lundbeck will have access to Genmab's antibody creation and development capabilities, including its state of the art, fully automated pre-clinical antibody screening and characterization capabilities and its proprietary stabilized IgG4 and UniBody therapeutic antibody platforms.
Neurosurgery researchers at UC Davis Health System have used a new, leading-edge stem cell therapy to promote the growth of bone tissue following the removal of cervical discs - the cushions between the bones in the neck - to relieve chronic, debilitating pain.
› Verified 1 days ago
| Provider Name | Brull & Honig Md Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1174579320 PECOS PAC ID: 6800807009 Enrollment ID: O20060602000152 |
News Archive
As the COVID-19 pandemic continues to cause an immense impact across many parts of the world, the role played by immune responses is becoming more evident every day. A recent funded paper published on the preprint server medRxiv* in September 2020 reports the initiation of a Phase I trial of a drug that increases antibody and cell-mediated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Iowa State researchers have found for the first time that less muscle and more body fat may affect our thinking as we age, and changes in parts of the immune system could be responsible.
Genmab A/S announced today an agreement to create and develop human antibody therapeutics for disorders of the central nervous system (CNS) with H. Lundbeck A/S. Genmab will create novel human antibodies to three targets identified by Lundbeck. Lundbeck will have access to Genmab's antibody creation and development capabilities, including its state of the art, fully automated pre-clinical antibody screening and characterization capabilities and its proprietary stabilized IgG4 and UniBody therapeutic antibody platforms.
Neurosurgery researchers at UC Davis Health System have used a new, leading-edge stem cell therapy to promote the growth of bone tissue following the removal of cervical discs - the cushions between the bones in the neck - to relieve chronic, debilitating pain.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason Thomas Palik, OD 23 Crossroads Dr, Suite #310, Owings Mills, MD 21117-5420 Ph: (410) 581-1500 | Dr Jason Thomas Palik, OD 23 Crossroads Dr, Suite #310, Owings Mills, MD 21117-5420 Ph: (410) 581-1500 |
News Archive
As the COVID-19 pandemic continues to cause an immense impact across many parts of the world, the role played by immune responses is becoming more evident every day. A recent funded paper published on the preprint server medRxiv* in September 2020 reports the initiation of a Phase I trial of a drug that increases antibody and cell-mediated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Iowa State researchers have found for the first time that less muscle and more body fat may affect our thinking as we age, and changes in parts of the immune system could be responsible.
Genmab A/S announced today an agreement to create and develop human antibody therapeutics for disorders of the central nervous system (CNS) with H. Lundbeck A/S. Genmab will create novel human antibodies to three targets identified by Lundbeck. Lundbeck will have access to Genmab's antibody creation and development capabilities, including its state of the art, fully automated pre-clinical antibody screening and characterization capabilities and its proprietary stabilized IgG4 and UniBody therapeutic antibody platforms.
Neurosurgery researchers at UC Davis Health System have used a new, leading-edge stem cell therapy to promote the growth of bone tissue following the removal of cervical discs - the cushions between the bones in the neck - to relieve chronic, debilitating pain.
› Verified 1 days ago
Dr. Brian Michael Granek, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 10995 Owings Mills Boulevard, Suite 204, Owings Mills, MD 21117 Phone: 410-363-0060 Fax: 410-363-0911 | |
Sterling Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10300 Mill Run Cir, Owings Mills, MD 21117 Phone: 410-363-3100 Fax: 410-363-8117 | |
Jeremy Goldman, O.d., Llc Optometrist Medicare: Medicare Enrolled Practice Location: 12621 Waterspout Ct, Owings Mills, MD 21117 Phone: 443-621-0756 | |
Dr. Mylinh Nguyen Delgado, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10300 Mill Run Cir, Suite 1000, Owings Mills, MD 21117 Phone: 410-363-0046 | |
Dr. Alisa Perle Mandel, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 9750 Reisterstown Rd, Walmart Vision Center, Owings Mills, MD 21117 Phone: 443-394-7124 Fax: 443-394-9511 | |
Vr Optical, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 10270 Mill Run Cir, Owings Mills, MD 21117 Phone: 410-929-4717 |